Hydromorphone Hydrochloride 00703-0113
Product NDC
00703-0113- Manufacturer
- Teva Parenteral Medicines, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- January 18, 2011
- Listing Expires
- December 31, 2027
- Application
- ANDA078591
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 10 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
10 VIAL in 1 CARTON (0703-0113-03) / 5 mL in 1 VIAL (0703-0113-01)